Correlation Between CERo Therapeutics and Noble Plc
Can any of the company-specific risk be diversified away by investing in both CERo Therapeutics and Noble Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CERo Therapeutics and Noble Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CERo Therapeutics Holdings, and Noble plc, you can compare the effects of market volatilities on CERo Therapeutics and Noble Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CERo Therapeutics with a short position of Noble Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of CERo Therapeutics and Noble Plc.
Diversification Opportunities for CERo Therapeutics and Noble Plc
0.06 | Correlation Coefficient |
Significant diversification
The 3 months correlation between CERo and Noble is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding CERo Therapeutics Holdings, and Noble plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Noble plc and CERo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CERo Therapeutics Holdings, are associated (or correlated) with Noble Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Noble plc has no effect on the direction of CERo Therapeutics i.e., CERo Therapeutics and Noble Plc go up and down completely randomly.
Pair Corralation between CERo Therapeutics and Noble Plc
Given the investment horizon of 90 days CERo Therapeutics Holdings, is expected to generate 11.1 times more return on investment than Noble Plc. However, CERo Therapeutics is 11.1 times more volatile than Noble plc. It trades about 0.06 of its potential returns per unit of risk. Noble plc is currently generating about -0.07 per unit of risk. If you would invest 8.40 in CERo Therapeutics Holdings, on September 15, 2024 and sell it today you would lose (2.73) from holding CERo Therapeutics Holdings, or give up 32.5% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
CERo Therapeutics Holdings, vs. Noble plc
Performance |
Timeline |
CERo Therapeutics |
Noble plc |
CERo Therapeutics and Noble Plc Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with CERo Therapeutics and Noble Plc
The main advantage of trading using opposite CERo Therapeutics and Noble Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CERo Therapeutics position performs unexpectedly, Noble Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Noble Plc will offset losses from the drop in Noble Plc's long position.CERo Therapeutics vs. Awilco Drilling PLC | CERo Therapeutics vs. Delek Drilling | CERo Therapeutics vs. Noble plc | CERo Therapeutics vs. Seadrill Limited |
Noble Plc vs. Helmerich and Payne | Noble Plc vs. Precision Drilling | Noble Plc vs. Sable Offshore Corp | Noble Plc vs. Seadrill Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |